Clinical trial
Kinesia-D Phase II In-Clinic Continuous Assessment Study
NCT02125825 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Kinesia-D Phase II In-Clinic Continuous Assessment Study
- Lead sponsor
- Great Lakes NeuroTechnologies Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- December 31, 2014
- Enrollment
- 14 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease